Company Contents
Quick Facts & Snapshot
Summary
The global Blood Collection market is entering a consolidation-driven growth phase, supported by infection-control mandates, automation in diagnostics, and expanding screening volumes. Leading Blood Collection market companies are strengthening portfolios across tubes, needles, and safety devices while targeting emerging markets. From 2025 to 2032, the sector is projected to grow at a robust 6.30% CAGR, reaching US$ 23.35 Billion.
Source: Secondary Information and ReportMines Research Team - 2026
Ranking Methodology
The ranking of Blood Collection market companies is based on a composite scoring model that integrates quantitative and qualitative criteria. Core metrics include estimated 2025 Blood Collection revenue, growth versus the market, and recurring revenue from consumables. We also assess project wins with hospital networks and diagnostic chains, installed base of collection systems, and portfolio breadth spanning tubes, needles, safety devices, lancets, and capillary products. Technology differentiation, regulatory track record, geographic coverage, and after-sales service capability are evaluated, alongside digital integration with laboratory information systems. Each company receives weighted scores across these dimensions, normalized on a 100-point scale. Scores are validated through triangulation of public filings, secondary research, and expert interviews, ensuring an objective view of competitive positioning.
Top 10 Companies in Blood Collection
Source: Secondary Information and ReportMines Research Team - 2026
Detailed Company Profiles
Becton, Dickinson and Company (BD)
Global medical technology leader dominating evacuated blood collection, safety needles, and pre-analytical systems for hospitals, labs, and blood centers worldwide.
Terumo Corporation
Japanese medtech major with strong presence in blood component collection, apheresis, and transfusion technologies for blood banks and plasma centers.
Greiner Bio-One International GmbH
European specialist in pre-analytical solutions, offering premium vacuum tubes and accessories for clinical laboratories and hospital networks.
SARSTEDT AG & Co. KG
Privately held German company delivering integrated blood collection, laboratory consumables, and automation-compatible pre-analytical systems.
Fresenius Kabi AG
Healthcare company serving transfusion medicine and infusion therapy, with a solid base in blood bag and component collection systems.
Haemonetics Corporation
US-based specialist delivering advanced blood management, apheresis, and software solutions for plasma centers and hospitals.
Nipro Corporation
Diversified Japanese manufacturer of medical devices with growing scale in needles, syringes, and blood collection consumables.
Cardinal Health, Inc.
Global healthcare distributor with significant private-label presence in blood collection and related disposables for hospitals.
Macopharma SA
French company specialized in blood bag systems, filters, and consumables for blood banks and transfusion services.
Improve Medical Instruments Co., Ltd.
China-based manufacturer scaling rapidly in vacuum blood collection tubes, needles, and safety devices for global OEM and branded markets.
SWOT Leaders
Becton, Dickinson and Company (BD)
SWOT Snapshot
Global scale, comprehensive portfolio across tubes and safety needles, and deep integration with lab workflows.
Premium pricing and dependence on large GPO contracts expose margins to aggressive tenders.
Growing demand for safety-engineered, traceable devices and expansion in high-growth emerging healthcare systems.
Low-cost competitors from Asia and potential regulatory shifts impacting device design and approvals.
Terumo Corporation
SWOT Snapshot
Technological leadership in apheresis and strong relationships with blood banks and plasma centers worldwide.
Less entrenched in routine hospital phlebotomy compared with top Western rivals.
Rising plasma collection volumes and global modernization of blood component processing.
Currency volatility, reimbursement pressure, and growing competition in apheresis technologies.
Greiner Bio-One International GmbH
SWOT Snapshot
High-quality pre-analytical products, strong European footprint, and focus on innovation and sustainability.
Smaller global sales and marketing footprint versus the largest multinationals.
Laboratory consolidation and demand for standardized, premium tube systems in North America and Asia.
Price-focused tenders, raw material cost fluctuation, and private-label competition from distributors.
Blood Collection Market Regional Competitive Landscape
North America remains the largest regional market, driven by high testing volumes, strong infection-control regulation, and rapid adoption of safety devices. Becton, Dickinson and Company (BD), Cardinal Health, and Haemonetics dominate contracts with hospital networks and reference labs, while niche Blood Collection market companies target specialized segments and private-label opportunities.
Europe shows balanced competition between global and regional champions. Greiner Bio-One, SARSTEDT, Fresenius Kabi, and Macopharma hold strong positions with national health systems and blood services. Tenders emphasize product quality, regulatory compliance, and sustainable packaging, shaping how Blood Collection market companies position their portfolios and pricing strategies.
Asia Pacific delivers the fastest growth, underpinned by expanding healthcare coverage, rising diagnostic testing, and modernization of blood services. Terumo, Nipro, and Improve Medical benefit from proximity to manufacturing hubs and local relationships, while Western Blood Collection market companies invest in partnerships and localized production to remain competitive on cost and supply reliability.
Latin America is characterized by budget constraints, uneven infrastructure, and high reliance on public tenders. Fresenius Kabi and Macopharma are prominent in blood banks, while BD and Greiner Bio-One compete in hospital segments. Price, training support, and robust supply chains are critical differentiators for Blood Collection market companies seeking sustainable regional share.
Middle East and Africa present fragmented but growing opportunities as countries invest in national blood programs and modern laboratory networks. SARSTEDT, Macopharma, and BD win business through turnkey solutions and training, while emerging Asian Blood Collection market companies enter via distributors, offering cost-effective alternatives to established brands.
In Eastern Europe and CIS markets, healthcare modernization programs and private lab consolidation are reshaping procurement patterns. Greiner Bio-One and SARSTEDT leverage premium positioning, while Improve Medical and Nipro introduce competitively priced solutions. Successful Blood Collection market companies balance affordability with regulatory compliance and consistent quality.
Blood Collection Market Emerging Challengers & Disruptive Start-Ups
Emerging Challengers & Disruptive Start-Ups
Develops AI-guided vein visualization and workflow software that integrates with phlebotomy carts to reduce failed venipuncture attempts and pre-analytical errors.
Offers recyclable and bio-based blood collection tubes designed to cut plastic waste, targeting hospitals with ambitious sustainability and ESG commitments.
Produces ultra-low-cost safety lancets and needles tailored for high-volume public health programs and emerging-market screening campaigns.
Provides compact, modular plasma and blood component collection devices aimed at decentralized donation centers and mobile blood drives.
Cloud-native platform enabling end-to-end barcoding, temperature tracking, and chain-of-custody analytics for blood samples, integrating with multiple LIS vendors.
Develops micro-volume capillary collection devices compatible with point-of-care analyzers, supporting decentralized diagnostics and telehealth workflows.
Blood Collection Market Future Outlook & Key Success Factors (2026-2032)
From 2025 to 2031, cumulative investments in metro expansions and station safety upgrades are projected to surpass significant amounts. The total market will scale from US$ 2.27 Billionin 2025 to US$ 3.38 Billion by 2031, reflecting a 6.90% CAGR. Winning Blood Collection market companies will share several attributes. First, they will embed native IoT sensors, enabling predictive maintenance contracts that can double recurring revenue within five years. Second, modular design philosophies—interchangeable panels, plug-and-play controllers—will shorten installation windows and appeal to cost-sensitive public operators.
Localization strategies will also define competitive edges. Suppliers that establish regional assembly plants to meet content rules in India, Brazil, or the U.S. are likely to capture bonus points in tenders. Finally, sustainability credentials will move from optional to mandatory. Recyclable composite panels, energy-efficient brushless motors, and life-cycle carbon disclosures will become bid differentiators. In short, the coming decade rewards Blood Collectionmarket companies that marry digital intelligence with manufacturing agility and regulatory foresight.
Frequently Asked Questions
Find answers to common questions about this company report.